Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China's National Reimbursement Drug List

BOSTON, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of…

Related Keywords

China ,Boston ,Massachusetts ,United States , ,Paratek Pharmaceuticals Inc ,China National Healthcare Security Administration ,National Healthcare Security Administration ,News ,Ggregator ,Reaking News ,Uration ,Media ,